Vistagen Therapeutics, Inc. (VTGN)

0.6731 +0.01 (+1.69%) USD  |  NASDAQ  |  Jan 02, 15:50
More

Vistagen Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for VTGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Omeros Corp. Upgrade
GeoVax Labs, Inc. Upgrade
Daré Bioscience, Inc. Upgrade